Education
About Us
Working with TipRanks
Follow Us
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
Capricor Therapeutics (CAPR) Ownership Overview
16.81% Insiders
6.62% Mutual Funds
0.04% Other Institutional Investors
10.83% ETFs
65.69% Public Companies and
Individual Investors
The ownership structure of Capricor Therapeutics (CAPR) stock is a mix of institutional, retail, and individual investors. Approximately 17.50% of the company’s stock is owned by Institutional Investors, 16.81% is owned by Insiders, and 65.69% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 24, 2024 | xxxxxxxxxxxxx | $14999998 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $8693089 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $31055520 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,090,351 | Insider | 15.52% | 69,627,247 | |
| 2,250,400 | Institution | 4.93% | 22,098,928 | |
| 2,126,293 | Institution | 4.66% | 20,880,197 | |
| 1,780,200 | Institution | 3.90% | 17,481,564 | |
| 1,495,756 | Institution | 3.27% | 14,688,324 | |
| 1,131,141 | Institution | 2.48% | 11,107,805 | |
| 629,934 | Institution | 1.38% | 6,185,952 | |
| 392,480 | Institution | 0.86% | 3,854,154 | |
| 282,380 | Institution | 0.62% | 2,772,972 | |
| 211,104 | Insider | 0.46% | 2,073,041 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,780,200 | Institution | 3.90% | 17,481,564 | |
| 392,480 | Institution | 0.86% | 3,854,154 | |
| 282,380 | Institution | 0.62% | 2,772,972 | |
| 164,330 | Institution | 0.36% | 1,613,721 | |
| 146,068 | Institution | 0.32% | 1,434,388 | |
| 111,336 | Institution | 0.24% | 1,093,320 | |
| 22,929 | Institution | 0.05% | 225,163 | |
| 17,890 | Institution | 0.04% | 175,680 | |
| 17,560 | Institution | 0.04% | 172,439 | |
| 16,008 | Institution | 0.04% | 157,199 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,190,276 | Institution | 2.61% | 18,306,445 | |
| 1,036,932 | Institution | 2.27% | 9,747,161 | |
| 956,636 | Institution | 2.09% | 9,394,166 | |
| 648,853 | Institution | 1.42% | 9,979,359 | |
| 276,996 | Institution | 0.61% | 2,720,101 | |
| 168,518 | Institution | 0.37% | 2,591,807 | |
| 107,397 | Institution | 0.24% | 1,009,532 | |
| 80,252 | Institution | 0.18% | 788,075 | |
| 61,443 | Institution | 0.13% | 603,370 | |
| 54,713 | Institution | 0.12% | 537,282 |
FAQ
Who Owns Capricor Therapeutics (CAPR)?
According to the latest TipRanks data, approximately 0.04% of the company's stock is held by institutional investors, 16.81% is held by insiders, and 65.69% is held by retail investors.
What percentage of Capricor Therapeutics (CAPR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.04% of Capricor Therapeutics (CAPR) stock is held by institutional investors.
What percentage of Capricor Therapeutics (CAPR) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.69% of Capricor Therapeutics (CAPR) stock is held by retail investors.
Who owns the most shares of Capricor Therapeutics (CAPR)?
Nippon Shinyaku Co., Ltd. owns the most shares of Capricor Therapeutics (CAPR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.